<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156732">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01059357</url>
  </required_header>
  <id_info>
    <org_study_id>CCCWFU 60209</org_study_id>
    <nct_id>NCT01059357</nct_id>
  </id_info>
  <brief_title>Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System</brief_title>
  <acronym>TORS</acronym>
  <official_title>A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct a pilot single-arm to assess transoral robotic
      surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da
      Vinci Robotic Surgical System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are going to be evaluated in their usual regular clinical follow ups starting with
      preoperative first visit, 3 weeks, 3 months and 6 months postoperatively with a Quality of
      Life survey (Head and Neck Cancer Inventory, HNCI-QOLQ).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2010</start_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>In order to evaluate the feasibility of TORS, the investigators will report the number and percent of all evaluable patients who have successfully undergone TORS at each interim analysis.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome measures are operative time, blood loss and complications, to assess the learning curve for TORS by measuring the efficiency and accuracy of the procedures, and to assess the quality of life of the patients undergoing TORS.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Head and Neck Neoplasms</condition>
  <arm_group>
    <arm_group_label>Transoral Robotic Surgery (TORS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transoral Robotic Surgery (TORS) using the Da Vinci Robotic Surgical System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Da Vinci Robotic Transoral Robotic Surgical System</intervention_name>
    <description>(TORS) Da Vinci Robotic Transoral Robotic Surgical System</description>
    <arm_group_label>Transoral Robotic Surgery (TORS)</arm_group_label>
    <other_name>(TORS) Da Vinci Robotic Transoral Robotic Surgical System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient must present with indications for diagnostic or therapeutic approaches for
             benign and malignant diseases of the oral cavity or laryngopharynx (including the
             neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate,
             posterior and lateral pharynx, glottic, supraglottic and subglottic larynx)

          -  Patients must have adequate transoral exposure of the oral cavity and laryngopharynx
             for TORS instrumentation

        Exclusion Criteria:

          -  Unexplained fever and/or untreated, active infection

          -  Patient pregnancy

          -  Previous head and neck surgery precluding transoral/robotic procedures

          -  The presence of medical conditions contraindicating general anesthesia or transoral
             surgical approaches
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua D. Waltonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>January 17, 2017</lastchanged_date>
  <firstreceived_date>January 21, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
